COM:KYMERATX
Kymera Therapeutics, Inc.
- Stock
Last Close
43.51
22/11 21:00
Market Cap
2.22B
Beta: -
Volume Today
559.06K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -21.47M - | -41.25M 92.14% | -45.59M 10.54% | -100.22M 119.81% | -154.81M 54.47% | -146.96M 5.07% | |
depreciation and amortization | 205K - | 825K 302.44% | 1.76M 113.70% | 2.40M 35.96% | 2.98M 24.20% | 3.56M 19.75% | |
deferred income tax | 1.57M - | -2.68M - | |||||
stock based compensation | 648K - | 1.20M 84.57% | 5.19M 333.95% | 24.97M 381.16% | 35.48M 42.08% | 43.12M 21.53% | |
change in working capital | 2.31M - | 56.69M 2,356.11% | 124.87M 120.27% | -61.92M 149.59% | -37.62M 39.24% | 2.68M 107.13% | |
accounts receivables | 148K - | -577K 489.86% | 577K 200% | -2.40M 516.12% | -15M 524.74% | ||
inventory | -148K - | 6.88M 4,747.97% | 8.71M 26.59% | 2.40M 72.43% | 23.37M 873.43% | ||
accounts payables | 824K - | 904K 9.71% | 990K 9.51% | 54K 94.55% | 253K 368.52% | 2.04M 705.53% | |
other working capital | 1.48M - | 55.78M 3,658.96% | 117.58M 110.77% | -71.26M 160.61% | -37.88M 46.85% | -7.73M 79.60% | |
other non cash items | 443K - | 443K 0% | 332K 25.06% | 5.83M 1,654.52% | 889K 84.74% | -2.55M 386.50% | |
net cash provided by operating activities | -17.86M - | 17.91M 200.24% | 88.13M 392.21% | -128.95M 246.31% | -153.09M 18.72% | -102.83M 32.83% | |
investments in property plant and equipment | -1.36M - | -532K 60.77% | -9.10M 1,609.77% | -1.60M 82.44% | -2.84M 77.58% | -34.48M 1,115.80% | |
acquisitions net | 413.49M - | 5.81M 98.60% | -20.52M 453.35% | -5.23M 74.52% | |||
purchases of investments | -15.95M - | -529.38M 3,218.18% | -456.40M 13.79% | -445.97M 2.29% | -189.15M 57.59% | ||
sales maturities of investments | 115.89M - | 358.17M 209.06% | 469.33M 31.04% | 363.52M 22.55% | |||
other investing activites | -413.49M - | -5.81M 98.60% | 20.52M 453.35% | 5.23M 74.52% | |||
net cash used for investing activites | -1.36M - | -16.49M 1,115.78% | -422.59M 2,463.31% | -99.83M 76.38% | 20.52M 120.55% | 139.89M 581.74% | |
debt repayment | -295K - | -371K 25.76% | -554K 49.33% | -849K 53.25% | -1.13M 33.10% | -76K 93.27% | |
common stock issued | 35.28M - | 196.67M 457.43% | 243.11M 23.61% | 149.82M 38.37% | 4.27M 97.15% | ||
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 53.23M - | 34.91M 34.41% | 93.14M 166.80% | 8.02M 91.39% | 4.30M 46.35% | ||
net cash used provided by financing activities | 52.93M - | 34.91M 34.05% | 289.26M 728.57% | 250.28M 13.48% | 153.00M 38.87% | 4.19M 97.26% | |
effect of forex changes on cash | |||||||
net change in cash | 33.71M - | 36.33M 7.76% | -45.20M 224.40% | 21.50M 147.57% | 20.43M 4.96% | 41.25M 101.89% | |
cash at beginning of period | 7.75M - | 41.46M 435.23% | 77.79M 87.63% | 32.59M 58.10% | 54.09M 65.96% | 74.53M 37.77% | |
cash at end of period | 41.46M - | 77.79M 87.63% | 32.59M 58.10% | 54.09M 65.96% | 74.53M 37.77% | 115.78M 55.35% | |
operating cash flow | -17.86M - | 17.91M 200.24% | 88.13M 392.21% | -128.95M 246.31% | -153.09M 18.72% | -102.83M 32.83% | |
capital expenditure | -1.36M - | -532K 60.77% | -9.10M 1,609.77% | -1.60M 82.44% | -2.84M 77.58% | -34.48M 1,115.80% | |
free cash flow | -19.22M - | 17.37M 190.39% | 79.03M 354.92% | -130.54M 265.17% | -155.92M 19.44% | -137.31M 11.94% |
All numbers in (except ratios and percentages)